Pfizer to buy Array for $10.64 bln
June 17 (Reuters) - Pfizer Inc PFE.N said on Monday it had agreed to acquire Array Biopharma Inc ARRY.O for $10.64 billion, which will grant it access to its cancer drugs.
The cash deal for $48 per share of Array represents a premium of about 62% to the stock's closing price on Friday.
(Reporting by Tamara Mathias in Bengaluru; Editing by James Emmanuel)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.